Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | -1.39% | +13.42% | +184.00% |
05-08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
04-16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
Evolution of the average Target Price on Lexaria Bioscience Corp.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lexaria Bioscience Corp.
Maxim |
EPS Revisions
- Stock Market
- Equities
- LEXX Stock
- Consensus Lexaria Bioscience Corp.